Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print December 5, 2007, doi:10.1212/01.wnl.0000284598.98525.d7)
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
01.wnl.0000284598.98525.d7v1
70/2/101    most recent
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dean, G.
Right arrow Articles by Compston, D.A.S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dean, G.
Right arrow Articles by Compston, D.A.S.
NEUROLOGY 2008;70:101-105
© 2008 American Academy of Neurology

HLA-DRB1 and multiple sclerosis in Malta

G. Dean, MD, T. W. Yeo, MSc, A. Goris, PhD, C. J. Taylor, PhD, R. S. Goodman, BSc, M. Elian, MD, A. Galea-Debono, MD, A. Aquilina, MD, A. Felice, MD, M. Vella, MD, S. Sawcer, PhD and D.A.S. Compston, PhD

From the Health Research Board, Dublin, Ireland (G.D.); Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK (T.W.Y., A.G., S.S., D.A.S.C.); Section for Experimental Neurology, Katholieke Universiteit Leuven, Leuven, Belgium (A.G.); Tissue Typing Laboratory, Addenbrooke’s Hospital, Cambridge, UK (C.J.T., R.S.G.); Central Middlesex Hospital, London, UK (M.E.); St. Luke’s Hospital, Guardamangia, MSD09, Malta (A.G.-D., M.V.); Maltese Blood Transfusion Service, Guardamangia, MSD09, Malta (A.A.); and Laboratory of Molecular Genetics, Department of Physiology and Biochemistry, Biomedical Sciences Building, University of Malta, Msida, MSD06, Malta (A.F.).

Address correspondence and reprint requests to Dr. Geoffrey Dean, 39 Nutley Rd., Donnybrook, Dublin 4, Ireland hrb{at}hrb.ie

Background: By comparison with the neighboring island of Sicily, the frequency of multiple sclerosis (MS) in Malta is remarkably low.

Methods: To explore whether the relative rarity of MS in Malta might be the result of lower population frequencies of major histocompatibility complex susceptibility alleles, we genotyped the HLA-DRB1 locus in 77 Maltese-born patients (97% of the prevalent unrelated native cases) and 206 Maltese controls. We made comparisons with previously published data for Sicily and other European countries.

Results: The anticipated association with HLA-DRB1*15, the main susceptibility allele in most other populations, was confirmed (pc = 0.009) but, in addition, we also observed an equally strong, and apparently protective, effect of the HLA-DRB1*11 allele (pc = 0.016). In comparison with previously published data from Sicily, we found that all HLA-DRB1 risk alleles were more common in Malta, whereas HLA-DRB1*11 was slightly less common.

Conclusions: The difference in prevalence seen between the neighboring islands of Malta and Sicily cannot be explained by differences in background HLA-DRB1 population allele frequencies, which if anything would predict a higher rate of disease in Malta than in Sicily.

Abbreviations: AFBAC = affected family-based controls; MS = multiple sclerosis; NTrans = nontransmitted; Trans = transmitted.


Editorial, see page 97

e-Pub ahead of print on December 5, 2007, at www.neurology.org.

*These authors contributed equally to this work as first authors.

This project was supported by the Wellcome Trust, the Multiple Sclerosis Societies of Great Britain and Northern Ireland and of the Republic of Ireland, and the NIH. T.W.Y. was supported by the Wellcome Trust and Cambridge Philosophical Society. A.G. is a Postdoctoral Fellow of the Research Foundation–Flanders (FWO–Vlaanderen).

Disclosure: The authors report no conflicts of interest.

Received December 11, 2006. Accepted in final form April 24, 2007.




This article has been cited by other articles:


Home page
NeurologyHome page
S. V. Ramagopalan, D. A. Dyment, A. D. Sadovnick, and G. C. Ebers
HLA-DRB1 AND MULTIPLE SCLEROSIS IN MALTA
Neurology, October 21, 2008; 71(17): 1379 - 1379.
[Full Text] [PDF]


Home page
NeurologyHome page
B. Fontaine and L. F. Barcellos
Evidence for a complex interaction between HLA-DRB1 and environmental factors in MS
Neurology, January 8, 2008; 70(2): 97 - 98.
[Full Text] [PDF]

Correspondence:

Read all Correspondence

HLA-DRB1 and multiple sclerosis in Malta
Sreeram V Ramagopalan, et al.
Neurology Online, 12 Mar 2008 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by AAN Enterprises, Inc.